作者: Rongyu Zang , Yanling Feng , Dongsheng Tu , Sheng Yin , Rong Jiang
DOI: 10.1016/S1470-2045(21)00006-1
关键词: Gynecologic oncology 、 Medicine 、 Internal medicine 、 Interim analysis 、 Cytoreduction Surgical Procedures 、 Carboplatin 、 Progression-free survival 、 Hazard ratio 、 Population 、 Docetaxel
摘要: Background The benefits of secondary cytoreduction for platinum-sensitive relapsed ovarian cancer are still widely debated. We aimed to assess the efficacy of secondary cytoreduction …